Tag Archives: AstraZeneca

hATTR-PN Drug WAINUA™ Available at Orsini Specialty Pharmacy

WAINUA™ for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis is available at Orsini Specialty Pharmacy

Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap

Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap

AstraZeneca’s Saphnelo to Compete with GSK’s Benlysta to Treat Lupus

Saphnelo, while primarily available through the leading specialty drug distributors, is also available through Amber Specialty Pharmacy and US Bioservices

Blues Plans Pharmacy Solutions Venture Evio Targets Outcomes-Based Drug Contracts

Evio will work to improve medication affordability and patients’ clinical outcomes and medication experiences. The five plans in total provide coverage to more than 20 million members across the United States.

Highmark’s Strategy to Contain Drug Costs Includes an Increasing Number of Outcome-Based Contracts

Pharmaceutical manufacturers and payers have developed a number of agreements under which reimbursement is contingent on specific outcomes over the last few years

Onco360’s Pharmacy Network the Choice for New Oncology Treatments

Onco360, a subsidiary of PharMerica, is one of the nation’s leading providers of Oncology Pharmacy services

BrightInsight Growing its Number of Biopharma Partnerships

BrightInsight’s platform is designed for pharmaceutical and medtech companies that want their devices and drug-delivery systems to talk to each other and generate usable information

BMS Implementing Digital Therapeutics Strategy

BMS digital strategy has required thinking differently about the type of value-based relationships the company wants to establish